Displaying drugs 7426 - 7450 of 13634 in total
AVA-6000
Investigational
pGM169/GL67A
Investigational
N(2)-(2-carboxyethyl)-L-arginine
Experimental
L-2,4-diaminobutyric acid
Experimental
Clofoctol
Experimental
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
Chicory leaf
Chicory leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Chicory leaf is a plant/plant extract used in some OTC (over-the-counter) products. …
Peldesine
Peldesine is a potent inhibitor of human CCRF-CEM T-cell proliferation. It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections.
Investigational
Matched Description: … Peldesine is a potent inhibitor of human CCRF-CEM T-cell proliferation. ... It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections. …
Tribenoside
Anti-inflammatory agent used in edema of extremities, varicose veins & phlebitis.
Experimental
Matched Description: … Anti-inflammatory agent used in edema of extremities, varicose veins & phlebitis. …
Matched Categories: … Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use …
Matched Categories: … Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use …
Nemonoxacin
Investigational
Matched Categories: … Antibacterials for Systemic Use ... Antiinfectives for Systemic Use …
SRP 299
SRP 299 is a preparation of killed Mycobacterium vaccae that has been tested in uses related to inhibiting periodontal disease, in treating asthma and in treating eczema, itching and inflammation. Mycobacterium vaccae is a non-pathogenic, saprophytic bacteria whose antigens can be used to induce peripheral immune activation through the activity...
Investigational
Matched Description: … SRP 299 is a preparation of killed Mycobacterium vaccae that has been tested in uses related to inhibiting ... A specific subset of serotonergic neurons in the interfascicular part of the dorsal raphe nucleus (DRI ... periodontal disease, in treating asthma and in treating eczema, itching and inflammation. …
acetylleucyl-leucyl-norleucinal
Experimental
2,4-deoxy-4-guanidino-5-N-acetyl-neuraminic acid
Experimental
Talnetant
Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.
Investigational
Matched Description: … researched for several different functions, primarily for irritable bowel syndrome and as a potential ... Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being ... antipsychotic drug for the treatment of schizophrenia. …
Apomab
Apomab is under investigation in clinical trial NCT00851136 (A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)).
Investigational
Matched Description: … Apomab is under investigation in clinical trial NCT00851136 (A Study of PRO95780 Administered in Combination ... With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent …
BZL101
BZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of action. BZL101 targets diseased cells while leaving normal cells healthy and intact.
Investigational
Matched Description: … BZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of …
Ezeprogind
Investigational
Platelet Activating Factor
Experimental
9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide
9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA.
Experimental
PH94B
PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder). It is a member of a new family of pharmaceutical compounds called vomeropherins.
Investigational
Matched Description: … It is a member of a new family of pharmaceutical compounds called vomeropherins. ... PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized …
Oregovomab
Oregovomab is a murine monoclonal antibody that attaches to the tumor-associated antigen CA125.
Investigational
Matched Description: … Oregovomab is a murine monoclonal antibody that attaches to the tumor-associated antigen CA125. …
Matrix-M
Matrix-M is a saponin-based adjuvant made of nanometer particles, cholesterol, and phospholipid that is developed by Novavax. This compound is administered alongside vaccines to enhance biological functions: creating robust and long-lasting immune responses that may allow for dose-sparing of vaccines.
Investigational
Matched Description: … Matrix-M is a saponin-based adjuvant made of nanometer particles, cholesterol, and phospholipid that ... vaccines to enhance biological functions: creating robust and long-lasting immune responses that may allow for …
CYT007-TNFQb
CYT007-TNFQb is an active immunization therapy that aims at
providing a novel treatment to people suffering from RA or psoriasis. The vaccine should allow for administration of low
amounts of drug to individual patients (in the microgram range) and for convenient dosing schedules.
Investigational
Matched Description: … The vaccine should allow for administration of low
amounts of drug to individual patients (in the microgram ... CYT007-TNFQb is an active immunization therapy that aims at
providing a novel treatment to people suffering ... range) and for convenient dosing schedules. …
Displaying drugs 7426 - 7450 of 13634 in total